Concepedia

Nadia Cordua

NC

6

Publications

152

Citations

6

H-Index

2018

Active since

Affiliations

Humanitas University(Current)

IRCCS Humanitas Research Hospital

Istituti di Ricovero e Cura a Carattere Scientifico

University of Chicago

Istituto Oncologico Veneto

Nadia Cordua is an author at Humanitas University specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2018–2024

6

Publications

6

Avelumab plus axitinib in unresectable or metastatic type B3 thymomas and thymic carcinomas (CAVEATT): a single-arm, multicentre, phase 2 trial

Fabio Conforti, Paolo Andrea Zucali, Laura Pala et al. · The Lancet Oncology · 2022 · 54 citations

, , +6

STYLE (NCT03449173): A Phase 2 Trial of Sunitinib in Patients With Type B3 Thymoma or Thymic Carcinoma in Second and Further Lines

Claudia Proto, Sara Manglaviti, Giuseppe Lo Russo et al. · Journal of Thoracic Oncology · 2023 · 25 citations · Full text

, , +8

Efficacy and safety of ramucirumab plus carboplatin and paclitaxel in untreated metastatic thymic carcinoma: RELEVENT phase II trial (NCT03921671)

Claudia Proto, M. Ganzinelli, Sara Manglaviti et al. · Annals of Oncology · 2024 · 24 citations · Full text

Resound Trial: A phase 2 study of regorafenib in patients with thymoma (type B2‐B3) and thymic carcinoma previously treated with chemotherapy

Matteo Perrino, Tommaso De Pas, Silvia Bozzarelli et al. · Cancer · 2021 · 22 citations · Full text

Prognostic Significance of Organ-Specific Metastases in Patients with Metastatic Upper Tract Urothelial Carcinoma

Antonio Tufano, Nadia Cordua, Valerio Nardone et al. · Journal of Clinical Medicine · 2022 · 17 citations · Full text

, , +19

Rows per page

1–5 of 6